Abbvie Deutschland Gmbh and Co Kg

Glaswerke Arnold Gmbh & Co. Kg

Saint-augustin Canada Electric Inc.

Soitec Solar Gmbh

Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.

Abbott Gmbh & Co Kg

Nice Solar Energy Gmbh

Schmidt, Christoph

Christoph Schmidt

Joerg Rosenberg

Jörg Breitenbach

Jörg Rosenberg

Bernd Liepold

Thomas Kessler

Kennan C Marsh

Matthias Degenhardt

Ute Lander

Harald Krull

Gunther Berndl

Frank Dimroth

Andreas Bett

Gerrit Lange

Hansjörg Lerchen-Müller

Wolfgang Aipperspach

Jorg Rosenberg

Joerg Breitenbach

Kennan Marsh

Hansjörg LERCHENMÜLLER

A stacking spacer for a photovoltaic module frame comprises a main body, extending in a longitudinal direction, a connecting member, extending in the longitudinal direction and protruding from the main body, adapted for being inserted in at least one lateral profile groove of the photovoltaic module frame, and two opposed support members, arranged on respective opposed longitudinal sides of the main body, extending in the longitudinal direction, wherein the two opposed support members have complementary forms, whereby at least two stacking spacers can be securely stacked on top of each other. Photovoltaic module frames and tracking device assemblies may include photovoltaic modules comprising such stacking spacers.

Stacking spacer, photovoltaic module frame and tracking device assembly

Pharmaceutically acceptable solubilizing compositions comprising (i) at least one tocopheryl compound having a polyalkylene glycol moiety and (ii) at least one alkylene glycol fatty acid monoester or mixture of alkylene glycol fatty acid mono-and diester are disclosed. The solubilizing compositions are useful in the manufacture of pharmaceutical dosage forms comprising a melt-processed mixture of at least one active ingredient and at least one pharmaceutically acceptable polymer. The solubilizing compositions enhance the bioavailability of the active ingredient following oral intake.

Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

A process for producing a solid dispersion of an active ingredient which comprises feeding the active ingredient and a matrix-forming agent to an extruder and forming a uniform extrudate, wherein the extruder comprises at least two rotating shafts (), each of the shafts () carrying a plurality of processing elements disposed axially one behind the other, the processing elements defining (i) a feeding and conveying section (R; A), (ii) at least one reverse-flight section (D), and (iii) a discharging section (E), wherein the processing elements defining the reverse-flight section (R; D) comprise at least one reverse-flight element () which is based on a screw-type element having a conveying direction being opposite to the general conveying direction of the extruder.

Process for producing a solid dispersion of an active ingredient

The invention relates to a photovoltaic concentrator module with multifunction frame and also to a method for production thereof. The concentrator module has a lens- and a base plate, between which a frame extends. Between the lens plate and the frame and/or the base plate and the frame, two sealing compounds and/or adhesive compounds extend, which compounds differ with respect to their hardening time and/or gas permeability.

Photovoltaic concentrator module with multifunction frame

A process for producing a solid dispersion of an active ingredient which comprises feeding the active ingredient and a matrix-forming agent to an extruder and forming a uniform extrudate, wherein the extruder comprises at least two rotating shafts (), each of the shafts () carrying a plurality of processing elements disposed axially one behind the other, the processing elements defining (i) a feeding and conveying section (A), (ii) at least one mixing section (B), and (iii) a discharging section (E), wherein the processing element(s) defining the mixing section (B) comprise(s) a mixing element () that is derived from a screw type element (FIG.).

A pharmaceutically acceptable solubilizing composition comprising (i) at least one tocopheryl compound having a polyalkylene glycol moiety and (ii) at least one alkylene glycol fatty acid monoester or mixture of alkylene glycol fatty acid mono- and diester is disclosed. The solubilizing composition is useful in the manufacture of a pharmaceutical dosage form which comprises a melt-processed mixture of at least one active ingredient, at least one pharmaceutically acceptable polymer. The active ingredient(s) may be inhibitors of HIV protease. The solubilizing composition enhances the bioavailability of the active ingredient after oral intake.

The invention relates to a photovoltaic insulating glazing comprising a multi-layer glazing with a photovoltaic module. The glazing is further characterized in that two contact strips for contacting the photovoltaic module are led out from an intermediate space between the glass layers and a spacer spaces the glass layers apart, thereby forming the intermediate space.

Photovoltaic insulating glazing

A transparent thermal insulation arrangement for heating buildings with solar energy includes a glass plate, and absorber and an edge bond between the glass plate and the absorber. The absorber has an absorber plate which is inherently rigid and is assembled with the glass plate by the edge bond. An intermediate space is formed between the glass plate and the absorber plate and is filled with an inert gas. In addition, a space is formed between the absorber plate and the wall of the building which may be filled with air.

Transparent thermal insulation device

Growing community of inventors

Gunzenhausen, Germany

Christoph Schmidt